Call for Abstract

2nd Middle East Heart Congress, will be organized around the theme “Fostering the Excellence in Cardiac Science”

Heart 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Heart 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Anticoagulants or Blood Thinners
  • Track 1-2Antiplatelet Agents
  • Track 1-3Thrombolytic Agents
  • Track 2-1Stress test evaluations
  • Track 2-2Hemodynamic monitoring
  • Track 2-3Monitoring cardiac and vascular readings
  • Track 2-4Intensive hemodialysis
  • Track 3-1Atrial myxoma, tricuspid stenosis
  • Track 3-2Benign cardiac tumors, cardiac fibroma
  • Track 3-3Cardiac neoplasm, pulmonary chondroma
  • Track 3-4Carney complex, LAMB syndrome
  • Track 3-5Prevention of chemotherapy-induced cardiac dysfunction
  • Track 3-6Cancer and Heart
  • Track 4-1Open heart surgery
  • Track 4-2Heart transplant
  • Track 4-3Stem Cell Therapy
  • Track 4-4Surgical Treatment of Heart Failure
  • Track 5-1 Cardiac dysrhythmias
  • Track 5-2Bariatric surgery and cardiovascular risk
  • Track 5-3Heart attack
  • Track 6-1Vasodilators
  • Track 6-2Digoxin
  • Track 6-3Statins
  • Track 7-1Thrombolytic Agents
  • Track 7-2Angiotensin-converting Enzyme (ACE) Inhibitors
  • Track 7-3Angiotensin II Receptor Blockers (ARBs)
  • Track 8-1Case Reports on Cardiac Surgery
  • Track 8-2Case Reports on Cardiac Surgery
  • Track 8-3Case Reports on Vascular Heart Disease
  • Track 8-4Case Reports on Hypertension and Healthcare
  • Track 8-5Case Reports on Cardiac and Cardiovascular Research
  • Track 8-6Case Reports on Pediatric Cardiology
  • Track 9-1Beta Blockers or Beta-adrenergic Blocking Agents
  • Track 9-2Calcium Channel Blockers
  • Track 9-3Diuretics
  • Track 10-1Vitamin D intake and the risk of heart disease
  • Track 10-2Cardiopulmonary resuscitation
  • Track 10-3Prosthetic heart valves and associated complications
  • Track 10-4Thrombolytic therapy in stroke
  • Track 10-5Mental stress and its gender-specific link to coronary diseases
  • Track 11-1Atrial fibrillation
  • Track 11-2Atrial myxoma
  • Track 11-3Unstable angina
  • Track 12-1Transient ischemic Attack
  • Track 12-2Atherosclerosis
  • Track 12-3Atrial myxoma
  • Track 12-4Familial Hypercholesterolemia
  • Track 13-1Cardiac regenerative therapy
  • Track 13-2Trans differentiation during heart regeneration
  • Track 13-3Biomimetic heart valve replacement
  • Track 13-4Stem cell-derived engineered cardiac tissue
  • Track 13-5NSTEMI Guidelines
  • Track 14-1Pediatric heart physiology
  • Track 14-2Pediatric heart catheterization
  • Track 14-3Risk and diagnosis of disease
  • Track 14-4Pediatric angina
  • Track 14-5Pediatric diseases pathology
  • Track 15-1Angiology
  • Track 15-2Cardiac stroke
  • Track 15-3Cardiomyopathy